Public Participation in Genetic Policymaking

[1]  N. Holtzman.  Rare diseases, common problems: recognition and management. , 1978, Pediatrics.

[2]  R. M. Schmidt,et al.  Stigmatization of carrier status: social implications of heterozygote genetic screening programs. , 1978, American journal of public health.

[3]  R. Grover,et al.  Evaluation of the expanded newborn screening program in New York City. , 1978, Pediatrics.

[4]  M. Bader.  Oral contraceptives and myocardial infarction. , 1977, New England Journal of Medicine.

[5]  N. Holtzman.  Genetic screening: for better or for worse. , 1977, Pediatrics.

[6]  C. Scriver,et al.  Knowledge about and attitudes toward genetic screening among high-school students: the Tay-Sachs experience. , 1977, Pediatrics.

[7]  B. Childs,et al.  Tay-Sachs screening: social and psychological impact. , 1976, American journal of human genetics.

[8]  B. Childs,et al.  Tay-Sachs screening: motives for participating and knowledge of genetics and probability. , 1976, American journal of human genetics.

[9]  J. Veney,et al.  Consumer Participation and Social Accountability , 1976, Medical care.

[10]  L. Veatch.  Community boards in search of authority , 1975 .

[11]  N. Holtzman,et al.  Letter: Commission of Hereditary Disorders. , 1974, American Journal of Human Genetics.

[12]  F. Kavaler,et al.  Phase one of consumer participation in policies of 22 voluntary hospitals in New York City , 1972, American journal of public health.

[13]  J. Gustafson,et al.  Ethical and social issues in screening for genetic disease. , 1972, The New England journal of medicine.